November 5, 2025
1 min read

Supernus pauses new patient starts for Parkinson’s pump Onapgo, citing high demand

Some eight months into the launch of Onapgo, the Parkinson’s disease infusion pump Supernus Pharmaceuticals spent years fighting to get across the FDA finish line, the drugmaker is discovering that patients’ appetite for the wearable is more than it can currently handle.

Leave a Reply

Your email address will not be published.

Previous Story

Healthy Habits Slash Genetic Dementia Risk in Adults with Type 2 Diabetes

Next Story

CGIAR and HarvestPlus support national policy change to embed nutrition in every seed

Previous Story

Healthy Habits Slash Genetic Dementia Risk in Adults with Type 2 Diabetes

Next Story

CGIAR and HarvestPlus support national policy change to embed nutrition in every seed

Latest from Blog

NEWS CENTER Maine

Through in-depth storytelling, through direct contact on digital on social platforms, through long-standing community service programs like Coats & Toys for Kids, Project Heat and Buddy to Buddy, NEWS CENTER Maine is
Go toTop